LMO2 promotes tumor cell invasion and metastasis in basal-type breast cancer by altering actin cytoskeleton remodeling.

Oncotarget · 2017 · PMC5354749 · PMID 27880729

Europe PMC DOI

hedged sentence

0.1280

closest p · 2.6× alpha

0.1280

boldest claim

The sentences

did not reach statistical significancep =0.128not close (p > 0.1)

However, further analysis of the samples grouped by the PAM50 subtype revealed that, in basal-type breast cancers, LMO2 expression tended to be higher in samples with lymph node metastasis than in those without, although this difference did not reach statistical significance (Δ x ̄=0.261, p =0.128, Figure 1B ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.